Xenon Pharmaceuticals
XENE
XENE
60 hedge funds and large institutions have $173M invested in Xenon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
60
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$6.44M | |
| 2 | +$2.24M | |
| 3 | +$1.8M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.47M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$776K |
Top Sellers
| 1 | -$5.42M | |
| 2 | -$5.08M | |
| 3 | -$2.11M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1M |
| 5 |
IPC
Invesco Private Capital
New York
|
-$808K |